Literature DB >> 27448733

The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy by gestational age: various objections.

M J Wensink1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27448733     DOI： 10.1016/j.ajog.2016.07.033

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  4 in total

1.  Population Scale Retrospective Analysis Reveals Potential Risk of Cholestasis in Pregnant Women Taking Omeprazole, Lansoprazole, and Amoxicillin.

Authors:  Yonghong Zhang; Da Shi; Ruben Abagyan; Weina Dai; Mingyang Dong
Journal:  Interdiscip Sci       Date:  2019-05-20       Impact factor: 2.233

2.  Women successfully treated for severe intrahepatic cholestasis of pregnancy do not have increased risks for adverse perinatal outcomes.

Authors:  Jielian Yang; Chong Chen; Min Liu; Shuye Zhang
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

3.  Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study.

Authors:  L B Manna; C Ovadia; A Lövgren-Sandblom; J Chambers; S Begum; P Seed; I Walker; L C Chappell; H-U Marschall; C Williamson
Journal:  BJOG       Date:  2019-09-26       Impact factor: 6.531

4.  Relationship between early onset severe intrahepatic cholestasis of pregnancy and higher risk of meconium-stained fluid.

Authors:  Maria C Estiú; Maria A Frailuna; Carla Otero; Marcela Dericco; Catherine Williamson; Jose J G Marin; Rocio I R Macias
Journal:  PLoS One       Date:  2017-04-24       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.